1. 1001TiPA phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer. (23rd October 2018) Authors: Wahner Hendrickson, A E; Costello, B; Jewell, A; Kennedy, V; Fleming, G; Corr, B; Taylor, S E; Lea, J; Reid, J; Swisher, E; Satele, D; Allred, J; Lensing, J; Ivy, S P; Erlichman, C; Adjei, A A; Kaufmann, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 36 Prognostic value and association with veliparib benefit of modeled CA-125 elimination kinetics (KELIM) in patients with newly diagnosed ovarian cancer: analysis from the VELIA/GOG-3005 study. (13th November 2020) Authors: You, B; Fleming, G; Bookman, M; Moore, KN; Steffensen, KD; Coleman, RL Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 7-Steps medication reviews: analysis of medicine changes in acute medical wards. (30th November 2022) Authors: Brown, J; Hogg, A; Scullin, C; Fleming, G; Scott, M Journal: International journal of pharmacy practice Issue: Volume 30(2022)Supplement 2 Page Start: ii7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin. (24th July 2014) Authors: Liong, S; Di Quinzio, MKW; Fleming, G; Permezel, M; Rice, GE; Georgiou, HM Journal: BJOG Issue: Volume 122:Number 3(2015:Mar.) Page Start: 370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P224 Evaluation of inhaled corticosteroid related pneumonia mortality in patients with COPD who would not fit the criteria for inclusion in randomised controlled trials. (14th November 2013) Authors: Singanayagam, A; Schembri, S; Akram, AR; Archibald, R; Peet, L; Fleming, G; Taylor, J; Williamson, P; Short, P; Chalmers, J Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rapid review of pharmacy services changed in response to Covid-19 in Northern Ireland. ([2020]) Authors: Scott, M; Fleming, G; Martin, S; Medicines Optimisation Innovation Centre, Other Names: Northern Ireland. Department of Health, commissioning body. Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S27 Cardiovascular events following Clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies. (19th November 2012) Authors: Singanayagam, A; Short, P; Williamson, P; Akram, A; Fleming, G; Taylor, J; Higgins, S; Mills, D; Singanayagam, A; Archibald, R; Peet, L; Hill, AT; Chalmers, JD; Schembri, S Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Using co-design to develop an online intervention for families after a sudden cardiac death in the young. (29th July 2021) Authors: Yeates, L; Gardner, K; Do, J; Van Den Heuvel, L; Fleming, G; Semsarian, C; Mcewen, A; Adlard, L; Ingles, J Journal: European journal of cardiovascular nursing Issue: Volume 20(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗